Ermine Bolot


Ermine Bolot


Paris | 32 rue de Monceau, Paris, France 75008
+33 1 57 57 80 08 | +33 1 57 57 80 81


Ermine Bolot advises strategic buyers and sellers in connection with complex domestic and cross-border M&A transactions, including, joint-ventures, carve-outs, and the sales/acquisitions of distressed companies.

Ms. Bolot is particulary experienced in advising clients on inbound and outbound transactions in the food, agribusiness, highly engineered industrial products, life sciences, energy and chemical sectors. She is also recognized for her ability to effectively lead multi-jurisdictional teams on international transactions in both emerging and established markets. In this context, Ermine has notable expertise in compliance and foreign investments issues arising in M&A transactions.

Consistently recognized by legal directories, Chambers Global 2020 ranks her in Corporate/M&A in France and cites that clients report her to be "an excellent communicator" and note her "great availability and quick responses." She is also recommended by The Legal 500 EMEA 2019 in Mergers and Acquisitions, the publication describing her as an "astute” lawyer who “knows how to address the challenges of an international industrial group” and praises her “ability to propose innovative angles in negotiations.” She is also recognized for M&A in France by IFLR1000 2020, Décideurs 2020 and listed among leading lawyers in France by Best Lawyers 2021. 

  • A worldwide leader in the chemical industry in connection with the acquisition of Lambson Limited (and its affiliates).
  • A worldwide leader in the chemical industry on the acquisition, through its subsidiary Bostik, of Prochimir S.A.S. (and its US subsidiary), specialized in the development and the production of high performance thermobonding adhesive films for industrial companies.
  • Canadian Group Sani-Marc on its acquisition of the assets of distressed French company Copak, a manufacturer of high-end maintenance products, as part of a bankruptcy process under the jurisdiction of the Commercial court of Rouen.
  • A U.S. multinational food and beverage company on the sale of one of its non-core and distressed industrial sites in France to a German turnaround fund. 
  • The shareholders of Neovia, majority owned (67.5%) by InVivo alongside minority investors Eurazeo, Unigrains, Future French Champions (CDC International Capital) and IDIA Capital Investissement (Crédit Agricole), on the sale of 100% of the shares of Neovia to Archer Daniels Midland Company (ADM), valuing the company at €1.535 billion.
  • A leading Anglo Saxon life sciences group in connection with the sale (and numerous related carve out issues) of two manufacturing sites and related businesses in North Africa to another strategic life sciences group. 
  • A large European pharmaceutical company on negotiating and reaching a settlement to terminate and dissolve a Chinese distribution Joint Venture. 
  • HGH Infrared Systems and its shareholders in the bidding process implemented by Rothschild for the sale of a controlling interest in HGH and in the subsequent sale thereof to US fund, Carlyle.
  • An international leader in cosmetics on the acquisition of all of the quotas and voting rights held by its partner in their joint venture in Italy.
  • Groupe Beneteau on negotiations with Polish yacht manufacturer Delphia Yachts, with the intent to acquire its operations of designing, building and marketing sailing and motor yachts under the Delphia Yachts and Maxi Yachts brands.
  • Crown European Holdings, the French holding of the global leader in consumer packaging, on the French-related aspects of its acquisition of Signode Industrial Group Holdings (Bermuda) Ltd., a leading global provider of transit packaging systems and solutions, from The Carlyle Group, in a cash transaction valued at US$3.91 million.
  • Stanley Black & Decker on the disposal of several businesses in Europe (e.g., Spain or Italy) and in their acquisitions of several monitoring businesses in Europe (e.g., Belgium or the UK).
  • A U.S.-based multinational industrial manufacturer on an acquisition project in France with a strong restructuring component and two other asset deals requiring the coordination of multijurisdictional teams.
  • A French dairy multinational on the disposal of three of its French and Belgian sites (and related carve out issues) to a US co-packer.
  • Orange S.A. on several acquisitions or divestitures in emerging markets (mainly Africa).
  • Université Paris 1 Panthéon-Sorbonne, DEA, International Private and Business Law, 1993
  • Université Paris 2 Panthéon-Assas, DEA, EU Laws, 1993
  • New York University School of Law, LL.M., 1994
  • Paris
  • English
  • French
  • German
Speaking Engagements
  • Compliance and M&A, seminar to Legal Departments of strategic players, Dechert LLP – Paris (Since 2017)
  • M&A : les enjeux de la Compliance, Le Figaro — Paris (March 17, 2020 and June 17, 2020) 
  • Representations and Warranties in M&A Transactions, ICC Institute Masterclass on International Contracts, ICC — Paris (December 6, 2019)  
  • CFIUS for Non-U.S. Investors: What French Investors Need to Know About New U.S. Restrictions, Dechert LLP —  Paris (February 20, 2019)
  • Agencies and General Counsel: What's on their Radar?, 5th Annual Global Merger Control Conference — Paris (December 8, 2017)
  • M&A : la reprise encourage la prise de risques, Magazine des Affaires Round Table – Paris (June 1, 2017)
  • Actualité M&A : Impact de la Réforme du Droit des Contrats sur les Processus de M&A et Rappels en Matière de Gun Jumping, Dechert LLP — Paris (January 31, 2017)
  • Les Rencontres M&A : stratégie, deal et intégration, Option Finance — Paris (November 6, 2015)
  • Paris Screening of 'A Price Worth Paying?', Dechert LLP and The Association des Responsables de Fusions Acquisitions — Paris (October 1, 2014)
  • Europe for Sale? European M&A Opportunities and Challenges in 2013 — PLI, Webcast (March 18, 2013)
  • The “New Emerging Market”? M&A Opportunities and Challenges for US Companies in Europe, Dechert LLP — New York, NY (October 3, 2012)